multiple sclerosis

Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Thu, 01/21/10 - 09:01 am
MS
multiple sclerosis
Novartis
Merck KGaA
Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent
Yahoo/AP
Wed, 01/13/10 - 09:22 am
Biogen Idec
Tysabri
MS
multiple sclerosis
Biogen says 48,800 patients now on Tysabri
Marketwatch
Tue, 01/12/10 - 09:15 am
Biogen Idec
Tysabri
multiple sclerosis
Adeona Announces Additional $860,000 Grant for Oral Estriol Multiple Sclerosis Clinical Trial
Trading Markets
Sun, 01/10/10 - 11:37 am
Adeona
multiple sclerosis
Can Novartis Win Race to Launch First Oral Drug for MS?
BNET Pharma
Fri, 12/4/09 - 08:38 am
MS
multiple sclerosis
Novartis
Merck KGaA
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNET Pharma
Fri, 11/13/09 - 08:55 am
Biogen Idec
social media
FDA
Tysabri
MS
multiple sclerosis
Avanir shares jump on new Zenvia data
Fierce Biotech
Wed, 11/11/09 - 08:24 am
Zenvia
Avanir
MS
multiple sclerosis
Teva says it wants to add 3 more patents to suit against Moment and Sandoz over Copaxone
Yahoo/AP
Tue, 11/10/09 - 09:59 am
Teva Pharmaceuticals
Sandoz
Copaxone
Momenta
lawsuits
MS
multiple sclerosis
More PML Troubles for Biogen, Elan MS Drug
TheStreet.com
Thu, 10/29/09 - 10:28 am
Biogen Idec
Elan
PML
Tysabri
MS
multiple sclerosis
Reviving Tysabri
Forbes
Tue, 10/27/09 - 04:32 pm
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis
Whatever Tysabri Outcome, Biogen Idec Should Survive
BNET Pharma
Mon, 10/26/09 - 06:05 pm
Tysabri
MS
multiple sclerosis
Biogen Idec
Elan
FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
Thu, 10/22/09 - 09:14 am
Acorda Therapeutics
FDA
MS
multiple sclerosis
Fampridine-SR
Elan pins hopes on multiple sclerosis drug
FT.com
Wed, 10/21/09 - 09:22 am
Elan
MS
multiple sclerosis
Tysabri
JNJ
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Bloomberg
Fri, 10/9/09 - 09:30 am
Acorda Therapeutics
MS
multiple sclerosis
Fampridine-SR
Teva Drug Halved Risk of Full-Blown Multiple Sclerosis in Study
Bloomberg
Wed, 10/7/09 - 08:41 am
Teva Pharmaceuticals
MS
multiple sclerosis
Copaxone
Teva rivals advance on oral MS drug: Merck KGaA and Novartis have completed Phase III trials of their drugs, and are filing for approval
Trading Markets
Thu, 10/1/09 - 06:30 pm
Teva Pharmaceuticals
Novartis
multiple sclerosis
Merck KGaA
Why I'm Invested in Tysabri and Elan
Motley Fool
Thu, 10/1/09 - 04:17 pm
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis
More Questions Than Answers From Elan
Motley Fool
Wed, 09/30/09 - 06:08 pm
Elan
Biogen Idec
Tysabri
MS
multiple sclerosis
Good News for Novartis
Yahoo/Zacks.com
Wed, 09/30/09 - 09:51 am
Novartis
MS
multiple sclerosis
US regulators subpoena documents of brain disease with drugmaker Elan's Tysabri
Yahoo/AP
Wed, 09/30/09 - 06:50 am
Elan
Tysabri
PML
Biogen Idec
MS
multiple sclerosis

Pages